Avacta Group PLC (LSE:AVCT) - Share price


Stock Report

Avacta Group PLC AVCT

Last Price
GBX241.20

Day Change
-6.80|-2.74%

As of 06/05/2021
17:07:56 BST | GBX
Minimum 15 Minutes Delay.

Last Close248.00p
Day Range241.20 - 253.90
Mkt Cap628.40Mil
52-Wk Range82.00 - 291.80
Yield %-
ISINGB00BYYW9G87
Volume1,119,407
P/E-
P/S0.65
P/CF-0.35

Share Price

Total Returns 05/05/2021

 Chg (%)  
More ...
Avacta Group PLC6.44 
FTSE 100 TR GBP4.75
 
Financials
201720182019
More ...
Income Statement
Turnover2.742.764.12
Operating Profit-7.98-10.43-11.18
Net Profit-6.37-8.83-9.68
Reported EPS-9.77-13.49-8.76
Balance Sheet
Current Assets15.808.20-
Non Current Assets15.7515.26-
Total Assets31.5523.45-
Current Liabilities1.662.04-
Total Liabilities---
Total Equity29.8921.41-
Cash Flow
Operating Cash Flow-5.99-6.73-9.26
Net Change in Cash-0.36-3.951.29
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
22/10/2020SaleProfessor Dr. David Alastair MacLaughlin Smith180.28248,543448,073.00

Company Profile

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and pre|CISION tumor-targeted chemotherapy. The company operates in the United Kingdom, Rest of Europe, Asia, and North America.

Sector

Biotechnology

Index

FTSE AIM 100 , FTSE AIM All-Share

Next Event 28/05/2021

Annual Report
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE0.00
Op Mrgn0.00
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr. Trevor John Nicholls
Executive Director, Chief ExecutiveProfessor Dr. David Alastair MacLaughlin Smith
Executive Director, Chief Financial Officer and Company SecretaryMr. Tony Peter Gardiner
Non-Executive Director, ChairmanDr. Eliot Richard Forster, M.B.A.,PhD
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.